• DiscoveryProbe Protease Inhibitor Library: Mechanisms

  2026-09-10

  The DiscoveryProbe Protease Inhibitor Library enables mechanism-aware protease inhibition studies across biochemical and cellular models. This article connects its screening utility with a dynamic assay-design lesson from the DdmDE defense-system study, helping researchers distinguish target engagement from downstream cleavage.

• Vancomycin Workflows for MRSA Research

  2026-09-09

  Build more reproducible susceptibility, bactericidal, and resistance-mechanism assays with Vancomycin, a glycopeptide antibiotic that targets peptidoglycan precursor binding. This guide connects comparative susceptibility evidence with practical solvent controls, inoculum design, endpoint selection, and troubleshooting for MRSA and Clostridium difficile infection research.

• RIPA Lysis Buffer Strong for Protein Workflows

  2026-09-09

  RIPA Lysis Buffer Strong combines powerful detergent-mediated extraction with the flexibility to add a customized inhibitor cocktail. This makes it useful for Western blotting, immunoprecipitation, ELISA sample preparation, and selected kinase workflows involving animal cells or tissues.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-08

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, tissue staining, flow cytometry, and compatible ELISA workflows. It should not be treated as a universal secondary antibody: confirm goat primary-antibody compatibility, control Cy3 spectral overlap, and validate assay-specific dilution and incubation conditions before interpreting results.

• Angiotensin 1/2 (2-7): Assay Strategy

  2026-09-08

  Angiotensin 1/2 (2-7) is a defined peptide tool for dissecting renin-angiotensin signaling, vascular responses, and peptide-dependent receptor binding. This guide translates recent spike–receptor findings into practical assay-design, handling, and interpretation decisions.

• MPC, Lactate, and Histone Lactylation in CRC

  2026-09-07

  This 2025 study identifies mitochondrial pyruvate carrier (MPC) loss as a metabolic driver of lactate accumulation, histone lactylation, dendritic-cell dysfunction, and impaired antitumor immunity in colorectal cancer. Its experimental framework connects pyruvate handling to CD8+ T-cell activity and anti-PD-1 response, providing a useful model for studying metabolic-epigenetic regulation in the tumor microenvironment.

• Sumatriptan: From 5-HT1 Biology to Translation

  2026-09-07

  A translational perspective on Sumatriptan Succinate as a 5-HT1 receptor agonist, connecting receptor pharmacology and neuroinflammation research with a pediatric emergency-department pathway.

• Pyridostatin: From G4 Stabilization to Assay Logic

  2026-09-05

  Pyridostatin is a G-quadruplex stabilizer that connects DNA structure, telomere dysfunction, and disease phenotypes. This article develops an evidence-based assay framework that distinguishes established telomere applications from emerging RNA G-quadruplex and TDP-43 research.

• Perifosine (KRX-0401) for Reliable Cell Assays

  2026-09-04

  This scenario-based guide explains how Perifosine, SKU A8309, can support reproducible viability, proliferation, apoptosis, and Akt-pathway experiments. It connects reported concentration-dependent effects with practical handling, controls, endpoint selection, and evidence-aware interpretation.

• Novel Gemini QACs: Broad-Spectrum Biocidal Activity

  2026-09-04

  This Bioorganic Chemistry study synthesized and evaluated 16 octenidine-derived gemini quaternary ammonium compounds against bacteria, biofilms, fungi, and viruses. Several candidates outperformed octenidine or benzalkonium chloride in selected assays, while compounds 1 and 12 showed particularly useful combinations of antifungal activity, broad-spectrum efficacy, and reduced cytotoxicity.

• REV1–DHX36 and G-Quadruplex Replication

  2026-09-03

  The reference study identifies a direct REV1–DHX36 partnership that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its findings place REV1 at the intersection of helicase recruitment, PrimPol restraint, replication fidelity, and ATM/ATR stress signaling, providing a mechanistic framework for studying genome instability.

• GDC-0068: A Spatial Akt–mTOR Assay Framework

  2026-09-03

  GDC-0068 (RG7440) is a selective pan-AKT inhibitor for dissecting how Akt controls mTORC1-dependent growth, survival, and transcription. This article presents a biomarker-aware assay framework that distinguishes pathway inhibition from compartment-specific causality.

• Dual SMAD–Wnt Inhibition for iPSC-Derived RGCs

  2026-09-02

  Chavali and colleagues developed a chemically defined differentiation strategy that combines SMAD and canonical Wnt pathway inhibition to generate retinal ganglion cells from induced pluripotent stem cells with improved yield and reproducibility. The workflow produced cultures with more than 80% RGC purity and enabled further Thy-1-positive enrichment to nearly 95%, offering a practical platform for glaucoma modeling and RGC-focused regenerative research.

• CAFs, ANGPTL4-IQGAP1, and Prostate Cancer Resistance

  2026-09-02

  This study identifies a paracrine ANGPTL4-IQGAP1 signaling axis through which cancer-associated fibroblasts enhance mitochondrial biogenesis, oxidative phosphorylation, and chemoresistance in prostate cancer cells. Its integrated proteomic, metabolomic, interaction, imaging, and drug-screening strategy points to IQGAP1 and the CAF-derived metabolic signal as potential targets for improving docetaxel response, while requiring further validation in in vivo and clinical models.

• Cy5 Goat Anti-Mouse IgG for Exosome Assays

  2026-09-01

  Discover how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody supports sensitive mouse IgG detection in osteogenesis and exosome studies. This article connects fluorescent assay design with lithium-driven Wnt10a trafficking and β-catenin signaling.

8112 records 1/541 page Next 12345 下5页 Last page